Three decades of clinical trials have changed the face of HIV/AIDS.
Published in Focus on Patient Care
Scientists from around the world will gather at UAB in December to focus on HIV research and women, particularly collaborative research on women living with HIV and those at risk.
Antibody VRC01 proves safe for individuals infected with HIV-1 but only modestly controls the virus in participants who stop receiving antiretroviral therapy.

A UAB expert recommends international travelers consult with a physician four to six weeks prior to travel and learn medical risks and how to prevent illness while abroad. 

Published in News You Can Use
High mosquito and human population densities, combined with mosquito breeding conditions, are the central cause for Zika virus.
Published in Focus on Patient Care
A UAB physician provides information on risks, recommendations and effects of Zika virus for pregnant women.
Published in Focus on Patient Care
UAB has received a grant to develop and implement Ebola and infectious disease training to further protect health care and public safety workers.
Researchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.
Antibiotic use in acute and long-term care facilities is a focus of UAB’s antibiotic stewardship program.
Published in Focus on Patient Care
UAB professor leads study in Brazil to help further understand the effects of Zika virus during pregnancy.
An international clinical trial for a new HIV antibody, VRC01 begins in late spring at UAB as part of the Antibody Mediated Prevention study.
Part of the challenge is to do a better job of helping patients make their own, well-informed choices.
UAB assistant professor leads the way in providing therapy for HIV patients with chronic pain.
Couples needed for study on the prevention of bacterial vaginosis between women and their male counterparts.
Researcher focused on HIV and STD prevention in women will lead UAB School of Medicine Division of Infectious Diseases.
Published in Faculty Excellence
UAB is recruiting postpartum women who are still lactating, for a study on the effects of the antiretroviral drug used to prevent HIV transmission.
February 03, 2016

Zika answers

UAB's David Freedman, M.D., a professor of infectious diseases and a leading expert on international medicine and emerging diseases, discusses the Zika virus, touching on who is at risk, how to prevent infection and the likelihood of an United States outbreak.
Published in Service to Community
A UAB study reconfirms that single-dose azithromycin remains an effective treatment for chlamydia, especially when drug adherence is an issue.
The Central Alabama Caribbean American Organization shares Caribbean culture and is a resource for area students from the Caribbean.
Published in Student Experience
A UAB/Children’s of Alabama/Cincinnati Children’s study finds genetic risk for fatal inflammatory disorder linked to viral infection.
Page 1 of 3
Back to Top